- Home
- ESPR vs DOYU Comparison
ESPR vs DOYU Comparison
Compare ESPR & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- DOYU
- Stock Information
- Founded
- ESPR 2008
- DOYU 2014
- Country
- ESPR United States
- DOYU China
- Employees
- ESPR N/A
- DOYU N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- DOYU Computer Software: Programming Data Processing
- Sector
- ESPR Health Care
- DOYU Technology
- Exchange
- ESPR Nasdaq
- DOYU Nasdaq
- Market Cap
- ESPR 220.0M
- DOYU 195.9M
- IPO Year
- ESPR 2013
- DOYU 2019
- Fundamental
- Price
- ESPR $1.40
- DOYU $7.86
- Analyst Decision
- ESPR Buy
- DOYU Hold
- Analyst Count
- ESPR 6
- DOYU 1
- Target Price
- ESPR $6.50
- DOYU $7.00
- AVG Volume (30 Days)
- ESPR 5.1M
- DOYU 78.5K
- Earning Date
- ESPR 08-05-2025
- DOYU 09-11-2025
- Dividend Yield
- ESPR N/A
- DOYU 249.36%
- EPS Growth
- ESPR N/A
- DOYU N/A
- EPS
- ESPR N/A
- DOYU N/A
- Revenue
- ESPR $259,574,000.00
- DOYU $575,786,186.00
- Revenue This Year
- ESPR $6.10
- DOYU N/A
- Revenue Next Year
- ESPR N/A
- DOYU N/A
- P/E Ratio
- ESPR N/A
- DOYU N/A
- Revenue Growth
- ESPR 12.99
- DOYU N/A
- 52 Week Low
- ESPR $0.69
- DOYU $5.68
- 52 Week High
- ESPR $3.94
- DOYU $20.17
- Technical
- Relative Strength Index (RSI)
- ESPR 58.85
- DOYU 48.90
- Support Level
- ESPR $1.13
- DOYU $8.45
- Resistance Level
- ESPR $1.74
- DOYU $9.34
- Average True Range (ATR)
- ESPR 0.17
- DOYU 0.51
- MACD
- ESPR 0.01
- DOYU -0.04
- Stochastic Oscillator
- ESPR 30.61
- DOYU 12.13
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.